R. Paul Fonteyne

Insider Reports History

Location
C/O Restorbio, Inc., 501 Boylston Street Suite 6102, Boston, MA
Signature
/s/ David Watson, attorney-in-fact for Paul Fonteyne
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by R. Paul Fonteyne:

Insider Reports Filed by R. Paul Fonteyne

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLS Apellis Pharmaceuticals, Inc. Jan 1, 2025 2 $0 4 Jan 3, 2025 Director
AMLX Amylyx Pharmaceuticals, Inc. Jun 6, 2024 1 $0 4 Jun 7, 2024 Director
APLS Apellis Pharmaceuticals, Inc. Jan 1, 2024 2 $344K 4 Jan 2, 2024 Director
AMLX Amylyx Pharmaceuticals, Inc. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
APLS Apellis Pharmaceuticals, Inc. Jan 1, 2023 2 $0 4 Jan 4, 2023 Director
CVET COVETRUS, INC. Oct 13, 2022 2 $0 4 Oct 13, 2022 Director
CVET COVETRUS, INC. Jul 1, 2022 2 $0 4 Jul 6, 2022 Director
AMLX Amylyx Pharmaceuticals, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
CVET COVETRUS, INC. May 11, 2022 1 $0 4 May 13, 2022 Director
GLSH GELESIS HOLDINGS, INC. May 6, 2022 1 $0 4 May 9, 2022 Director
GLSH GELESIS HOLDINGS, INC. Jan 13, 2022 0 $0 3 Jan 24, 2022 Director
AMLX Amylyx Pharmaceuticals, Inc. Jan 6, 2022 2 $75K 4 Jan 10, 2022 Director
AMLX Amylyx Pharmaceuticals, Inc. Jan 6, 2022 0 $0 3 Jan 6, 2022 Director
APLS Apellis Pharmaceuticals, Inc. Jan 1, 2022 2 $0 4 Jan 4, 2022 Director
CVET COVETRUS, INC. Aug 10, 2021 1 $116K 4 Aug 11, 2021 Director
CVET COVETRUS, INC. Jul 1, 2021 1 $0 4 Jul 6, 2021 Director
CVET COVETRUS, INC. Jul 1, 2021 0 $0 3 Jul 6, 2021 Director